Ophthalmology · Kissimmee, FL
NPI
1578763983
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2225 N Central Ave
Kissimmee, FL, 34741
Phone (407) 933-2908
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
975 services
Medicare patients, 2024
449
Average age 75
Drug cost, 2024
$548K
7,463 prescriptions
Company payments, 2025
$1,745
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Letbetter was code 92014 (ophthalmological e&m), 317 times for 274 patients. In total David Letbetter billed 975 services in 25 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 317 | 274 | $78.21 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 95 | 95 | $41.93 | $3,984 |
| 92133 Computerized Ophthalmic Imaging | Office | 90 | 90 | $24.25 | $2,182 |
| 92012 Ophthalmological E&M | Office | 83 | 67 | $59.74 | $4,958 |
| 92250 Angiography | Office | 68 | 68 | $21.84 | $1,485 |
| 92004 Ophthalmological E&M | Office | 61 | 61 | $88.65 | $5,408 |
| 92136 Ultrasound - Nonspecific | Office | 45 | 36 | $29.18 | $1,313 |
| 66984 Cataract Surgery | Facility | 41 | 32 | $421.57 | $17K |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $141.82 | $4,255 |
| 99214 Office E&M - Established | Office | 30 | 30 | $72.43 | $2,173 |
| 66821 Cataract Surgery | Facility | 26 | 19 | $224.72 | $5,843 |
| 76514 Ultrasound - Nonspecific | Office | 15 | 15 | $8.22 | $123 |
| 92002 Ophthalmological E&M | Office | 14 | 14 | $54.40 | $762 |
By year: 2022 $75K for 937 services; 2023 $91K for 1,078 services; 2024 $82K for 975 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Letbetter prescribed most often to Medicare patients was Latanoprost, with 2,248 prescriptions and refills. In total David Letbetter wrote 7,463 Medicare prescriptions that cost $548K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,248 | 4,867 | 653 | $20K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,317 | 2,882 | 408 | $19K |
| Brimonidine Tartrate Generic | 911 | 1,912 | 278 | $8,856 |
| Prednisolone Acetate Generic | 584 | 792 | 439 | $29K |
| Ketorolac Tromethamine Generic | 281 | 327 | 199 | $14K |
| Timolol Maleate Generic | 273 | 581 | 99 | $3,418 |
| Ofloxacin Generic | 253 | 288 | 206 | $6,759 |
| Lumigan Bimatoprost | 193 | 374 | 61 | $94K |
| Dorzolamide Hcl Generic | 179 | 366 | 70 | $2,296 |
| Cyclopentolate Hcl Generic | 160 | 173 | 143 | $1,434 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 157 | 159 | 110 | $1,607 |
| Rhopressa Netarsudil Mesylate | 144 | 268 | 54 | $82K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 126 | 202 | 35 | $66K |
| Travoprost Generic | 108 | 224 | 35 | $16K |
| Erythromycin Erythromycin Base | 98 | 100 | 55 | $1,202 |
Brand drugs: 2,269 claims; generic drugs: 5,194 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Letbetter $1,745 ($1,745 in general payments such as food, travel and fees) from 10 companies. The largest payer was Bausch & Lomb Americas Inc. with $553.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 6 | $553 |
| Glaukos Corporation GKOS | 2 | $342 |
| Tarsus Pharmaceuticals, Inc. TARS | 6 | $250 |
| Abbvie Inc. ABBV | 9 | $211 |
| Harrow Eye, LLC | 5 | $159 |
| Alcon Vision LLC ALC | 5 | $116 |
| Rayner Intraocular Lenses Limited | 1 | $41.91 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $28.55 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $23.01 |
| Dompe US, Inc. | 1 | $19.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.